Rebimastat (BMS-275291)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 12:40, 27 July 2023 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).

Also known as

  • Code names: BMS-275291, D2163
Retrieved from "https://hemonc.org/w/index.php?title=Rebimastat_(BMS-275291)&oldid=75789"